The Clinical Resource Core will provide support for the Human Research Projects (Projects II & III) of the U-M Udall Center through recruitment, enrollment, and detailed clinical and imaging assessment of Parkinson disease (PD) patients (N=95), progressive supranuclear palsy (PSP) patients (N=15), and age and gender matched normal control (NC) subjects (N=15). The Clinical Resource Core will have a standardized method for data collection, entry, and verification, as developed in coordination with the Biostatistics and Data Management Core (Core C), which will be in compliance with HIPAA and IRB regulations. Data collected will be consistent with NINDS Common Data Elements (CDEs) to facilitate ultimate transfer of data to a NINDS Data Management Repository (DMR). The Clinical Resource Core will interact on a regular basis with all other human subject components of the Udall Center. The specific goals of the Clinical Resource Core are: 1. To recruit, enroll, and retain PD, PSP, and age & gender matched NC subjects for the Udall Center Human Research Projects in support of their scientific goals. 2. To comprehensively assess all subjects with well-established clinical, motor, and neuropsychological instruments. 3. To perform vesicular monoaminergic transporter type-2 (VMAT2) positron emission tomography (PET) using [11C]DTBZ and brain magnetic resonance (MR) imaging. 4. To interact and coordinate with Projects II and III and other Cores to assure prompt and accurate clinical assessment, data transfer, and data analysis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
5P50NS091856-04
Application #
9329504
Study Section
Special Emphasis Panel (ZNS1)
Project Start
Project End
Budget Start
2017-07-01
Budget End
2018-06-30
Support Year
4
Fiscal Year
2017
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Miller, Nathaniel S; Chou, Kelvin L; Bohnen, Nicolaas I et al. (2018) Dopaminergic polymorphisms associated with medication responsiveness of gait in Parkinson's disease. Parkinsonism Relat Disord 48:54-60
Kalinin, Alexandr A; Allyn-Feuer, Ari; Ade, Alex et al. (2018) 3D Shape Modeling for Cell Nuclear Morphological Analysis and Classification. Sci Rep 8:13658
Beaulieu, Mélanie L; Müller, Martijn L T M; Bohnen, Nicolaas I (2018) Peripheral neuropathy is associated with more frequent falls in Parkinson's disease. Parkinsonism Relat Disord 54:46-50
Bohnen, Nicolaas I; Teipel, Stefan J (2018) Cholinergic forebrain density loss in Parkinson disease: More than just cognitive changes. Neurology 90:823-824
Rosso, Andrea L; Bohnen, Nicolaas I; Launer, Lenore J et al. (2018) Vascular and dopaminergic contributors to mild parkinsonian signs in older adults. Neurology 90:e223-e229
Bohnen, Nicolaas I; Grothe, Michel J; Ray, Nicola J et al. (2018) Recent advances in cholinergic imaging and cognitive decline-Revisiting the cholinergic hypothesis of dementia. Curr Geriatr Rep 7:1-11
Tang, Ming; Gao, Chao; Goutman, Stephen A et al. (2018) Model-Based and Model-Free Techniques for Amyotrophic Lateral Sclerosis Diagnostic Prediction and Patient Clustering. Neuroinformatics :
Nejad-Davarani, Siamak; Koeppe, Robert A; Albin, Roger L et al. (2018) Quantification of brain cholinergic denervation in dementia with Lewy bodies using PET imaging with [18F]-FEOBV. Mol Psychiatry :
Kotagal, Vikas; Albin, Roger L; Müller, Martijn L T M et al. (2018) Cardiovascular Risk Factor Burden in Veterans and Non-Veterans with Parkinson Disease. J Parkinsons Dis 8:153-160
Lin, Ming; Gong, Pinghua; Yang, Tao et al. (2018) Big Data Analytical Approaches to the NACC Dataset: Aiding Preclinical Trial Enrichment. Alzheimer Dis Assoc Disord 32:18-27

Showing the most recent 10 out of 100 publications